As traditional compound utilization and cost continue to decline, high impact therapeutic categories are emerging to take their place. In 2018, compound kits and combo packs each represented less than 1% of total prescriptions and drug costs. However, their presence is of growing concern due to the lack of evidence supporting their use and packaging strategies that are associated with exorbitant pricing. These and other challenges call for careful oversight that includes identification, clinical review and intervention, and/or recommendation of therapeutic alternatives where appropriate to help control inappropriate utilization and spend. Watch the video blog to learn more.
More stories
Auto Casualty
Article
Modernizing Claims Management: Streamlining Workflows With Integrated Negotiation Solutions
Negotiation Solutions Conventionally, the process of settling bodily injury claim
Workers' Comp
Article
Rising Temperatures and Rising Risks: Ensuring Workplace Safety with Enlyte's ClinicalCare24
As temperatures climb, so do the risks of workplace injuries related to heat.
Workers' Comp
Article
Specialty Solutions Spotlight: Emerging Workers' Comp Technology Trends
How are emerging technologies and trends in workers’ comp impacting workplace safety and rehabilitation? Technology and workplace safety
Workers' Comp
Case Study
Returning to the Same Employer in a Different Job
Workers' Comp
Article
Top Trends in P&C Networks
Workers' Comp
Case Study